BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31062127)

  • 1. Bishonokiol A inhibits breast cancer cell invasion and migration by suppressing hypoxia inducible factor-1α.
    Li HM; Miao J; Zhu M; Gao M; Dai Y; Huo Q; Ma T; Wu CZ
    J Bioenerg Biomembr; 2019 Jun; 51(3):239-248. PubMed ID: 31062127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
    Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
    Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
    Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of hypoxia-inducible factor-1 on tumor invasion and metastasis in breast cancer].
    Wang F; Chang MM; Zhao J; Jiang LL; Shi YH
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):99-103. PubMed ID: 21426805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
    Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X
    Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
    Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
    Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
    Smollich M; Götte M; Kersting C; Fischgräbe J; Kiesel L; Wülfing P
    Breast Cancer Res Treat; 2008 Mar; 108(2):175-82. PubMed ID: 17468950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
    Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
    Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
    Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
    Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.
    Kim YS; Lee HA; Lim JY; Kim Y; Jung CH; Yoo SH; Kim Y
    J Nutr Biochem; 2014 Jun; 25(6):655-64. PubMed ID: 24746828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
    Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
    PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
    Do HTT; Cho J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
    Hoffmann C; Mao X; Brown-Clay J; Moreau F; Al Absi A; Wurzer H; Sousa B; Schmitt F; Berchem G; Janji B; Thomas C
    Sci Rep; 2018 Jul; 8(1):10191. PubMed ID: 29976963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α.
    Naldini A; Filippi I; Miglietta D; Moschetta M; Giavazzi R; Carraro F
    Eur J Cancer; 2010 Dec; 46(18):3400-8. PubMed ID: 20801015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
    Liu J; Zhang C; Zhao Y; Yue X; Wu H; Huang S; Chen J; Tomsky K; Xie H; Khella CA; Gatza ML; Xia D; Gao J; White E; Haffty BG; Hu W; Feng Z
    Nat Commun; 2017 Nov; 8(1):1823. PubMed ID: 29180628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.